Efg Asset Management (Americas) Corp. Catalent, Inc. Transaction History

Efg Asset Management (Americas) Corp.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$45.44 - $74.26 $327,440 - $535,117	7,206 Added 25.69%	35,258 $2.32 Million
Q4 2022 Feb 09, 2023	BUY	$41.39 - $81.0 $283,935 - $555,660	6,860 Added 32.37%	28,052 $1.26 Million
Q3 2022 Nov 07, 2022	BUY	$72.36 - $113.1 $1.53 Million - $2.4 Million	21,192 New	21,192 $1.53 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.